ImmunityBio (NASDAQ: IBRX) is a mid-cap drugmaker making waves in this niche right now; the company's shares have soared over the last 12 months. Although ImmunityBio appears promising, investors ...

ANKTIVA plus BCG, with a 71% complete response rate, is the first immunotherapy to receive marketing authorization in Europe for non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) ...

ImmunityBio partner Accord Healthcare to deploy an 85-person sales force to drive ANKTIVA commercialization across 30 countries -- Dublin-based subsidiary to support ImmunityBio's distribution and ...

OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and 12 months ended December 31, 2025, and introduces financial ...

Editor’s note: This round‑up is based on press releases, peer‑reviewed publications, and company communications received in January and February 2026. All results are preliminary unless stated, and ...

PAI-1 Inhibitor (MDI-2517) demonstrates good safety and tolerability profile, with Phase 2 proof-of-concept trial planned for 2026 in patients with metabolic and fibrotic disease; ...

A new DNA immunotherapy, Elenagen, doubled survival (13 to 25+ months) for tough ovarian cancers when added to chemotherapy, with fewer side effects.

“She must remain silent because Ms. Maxwell has a habeas petition currently pending that demonstrates that her conviction ...

ISC Class 12 Biology Exam 2026 was conducted on 6 March 2026 from 2:00 PM to 5:00 PM by the Council for the Indian School Certificate Examinations (CISCE). Biology is an important subject for Class 12 ...

The exam evaluates conceptual understanding, clarity of expression, and the ability to apply biological knowledge to real-life situations. CHECK: CBSE Class 12 Biology Exam Pattern 2026 CBSE Class 12 ...

The UPMSP Class 12 Mathematics and Biology examinations 2026 concluded smoothly across Uttar Pradesh in the afternoon shift.

Did our AI summary help? The last few weeks before the Grade 12 Board exams are less about learning new things but more about revisiting and consolidating what you already know. In Senior Secondary ...